LuxContour

LuxContour ™
 
Tesa 13 MG + Ipamorelin 3 MG
 
Dual-Peptide Growth Hormone & Metabolic Research Blend
 
LuxContour is a dual-peptide research formulation combining Tesa and Ipamorelin (IPA).
 
Both compounds interact with the body's growth hormone signaling system, but they work through different receptors.
 
1. Tesa— 13 MG
What is it?
 
Tesa is a synthetic growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to release the body's own growth hormone.
 
Key Research Areas:
 
- Abdominal Fat: Clinically studied for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
 
- Growth Hormone Production: Stimulates natural growth hormone secretion.
 
- IGF-1 Signaling: Increases insulin-like growth factor 1, which participates in tissue growth and metabolism.
- Body Composition: Investigated for changes in abdominal fat distribution.
 
- Metabolic Regulation: Studied for its effects on growth hormone-related metabolic pathways.
 
 
 
Ipamorelin (IPA) — 3 MG
 
What Is It?
 
Ipamorelin is an investigational growth hormone secretagogue that activates the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R1a).
 
It is being studied for its ability to stimulate growth hormone release.
 
Key Research Areas:
 
- Growth Hormone Secretion:** Investigated for stimulating the body's natural GH release.
 
- Muscle Biology:Growth hormone signaling plays a role in tissue maintenance and protein metabolism.
 
- Body Composition:Researchers are interested in how GH-related pathways influence fat and lean tissue.
 
- Recovery Processes: Growth hormone pathways are involved in tissue repair, although clinical recovery benefits from ipamorelin have not been established.
 
- Sleep Physiology: Growth hormone secretion is linked to sleep,
 
 
 
Research Use Only — Not for Human or Animal Use.